WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1993020822) COMPOSITIONS OF PLATELET ACTIVATING FACTOR ANTAGONISTS AND METHODS OF TREATING INTERLEUKIN-2 INDUCED LUNG INJURY THEREWITH
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1993/020822    International Application No.:    PCT/US1993/003347
Publication Date: 28.10.1993 International Filing Date: 08.04.1993
Chapter 2 Demand Filed:    04.11.1993    
IPC:
A61K 31/44 (2006.01), A61K 31/55 (2006.01)
Applicants: SMITHKLINE BEECHAM CORPORATION [US/US]; Corporate Patents - U.S., UW2220, 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406-0939 (US) (For All Designated States Except US).
FEUERSTEIN, Giora, Z. [IL/US]; (US) (For US Only)
Inventors: FEUERSTEIN, Giora, Z.; (US)
Agent: DUSTMAN, Wayne, J.; SmithKline Beecham Corporation, Corporate Patents - U.S. (UW2220), 709 Swedeland Road, P.O. Box 1539, King of Prussia, PA 19406-0939 (US)
Priority Data:
9207645.4 08.04.1992 GB
Title (EN) COMPOSITIONS OF PLATELET ACTIVATING FACTOR ANTAGONISTS AND METHODS OF TREATING INTERLEUKIN-2 INDUCED LUNG INJURY THEREWITH
(FR) COMPOSITIONS D'ANTAGONISTES FACTEURS D'ACTIVATION DES PLAQUETTES ET METHODES DE TRAITEMENT DES LESIONS PULMONAIRES INDUITES PAR L'INTERLEUKINE 2 A L'AIDE DESDITES COMPOSITIONS
Abstract: front page image
(EN)Invented is a method of treating Interleukin-2 induced lung injury in a mammal, including human, which comprises administering to such mammal an effective amount of a platelet-activating factor antagonist.
(FR)L'invention concerne une méthode de traitement de lésions pulmonaires induites par l'interleukine 2 chez les mammifères, y compris chez l'homme, qui consiste à administrer audit mammifère, une quantité effective d'un antagoniste facteur d'activation des plaquettes.
Designated States: AU, CA, JP, KR, NZ, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: English (EN)
Filing Language: English (EN)